These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris. Saito M, Nobuyoshi M, Nakamura N, Nishiyama S, Haze K, Hiramori K, Ikeda M. Arzneimittelforschung; 1983 Jun; 33(9):1301-5. PubMed ID: 6685512 [Abstract] [Full Text] [Related]
25. [Hemodynamic and electrocardiographic prolonged nitrate effect during frequency load in coronary disease]. Wolf R, Beck OA, Guhl E, Hochrein H. Z Kardiol; 1976 May; 65(5):435-44. PubMed ID: 820104 [Abstract] [Full Text] [Related]
26. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?]. Reiniger G, Kraus F, Dirschinger J, Blasini R, Rudolph W. Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612 [Abstract] [Full Text] [Related]
30. Intravenous nitroglycerin: clinical use and efficacy. Curfman GD. Int J Cardiol; 1984 Feb; 5(2):241-4. PubMed ID: 6421757 [No Abstract] [Full Text] [Related]
31. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Glancy DL, Richter MA, Ellis EV, Johnson W. Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662 [Abstract] [Full Text] [Related]
32. [Comparison of the effects of depot peroral and transdermal administration of nitrate preparations]. Camek R, Karetová D, Bultas J, Krupicka P, Boudĭk F, Fabian E. Vnitr Lek; 1988 Feb; 34(2):122-9. PubMed ID: 3129873 [No Abstract] [Full Text] [Related]
33. [Effects on the systemic and coronary circulation of 2 nitrate derivatives, intravenous trinitrin and sublingual isosorbide dinitrate, administered during atrial pacing]. Fernandez F, Mechmeche R, Sprogis W, Baclet M, Gerbaux A. Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1227-31. PubMed ID: 121527 [Abstract] [Full Text] [Related]
34. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate. Weidemann H, Schuon J, Schober B. Z Kardiol; 1983 Nov; 72 Suppl 3():229-32. PubMed ID: 6666226 [Abstract] [Full Text] [Related]
35. [The possibility of the development of isosorbide dinitrate and nifedipine withdrawal syndromes in patients with stable stenocardia of effort]. Kutishenko NP, Martsevich SIu, Metelitsa VI. Ter Arkh; 1997 Nov; 69(9):47-51. PubMed ID: 9411826 [Abstract] [Full Text] [Related]
36. Comparison of placebo, nitroglycerin, and isosorbide dinitrate for effectiveness of relief of angina and duration of action. Kattus AA, Alvaro AB, Zohman LR, Coulson AH. Chest; 1979 Jan; 75(1):17-23. PubMed ID: 105834 [Abstract] [Full Text] [Related]
37. [Clinical effects of isosorbide dinitrate in the transdermal spray (TD Spray Iso Mack) form]. Vítovec J, Stejfa M, Blaha M, Nĕmcová H, Roubalík P, Spác J. Vnitr Lek; 1989 Aug; 35(8):758-64. PubMed ID: 2800383 [Abstract] [Full Text] [Related]
38. [Therapy of coronary heart disease with nitroglycerin patches. Behavior of anti-ischemic effectiveness in continuous administration and following patch free interval]. Reiniger G, Rudolph W. Herz; 1985 Oct; 10(5):305-11. PubMed ID: 3934055 [Abstract] [Full Text] [Related]
39. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration]. Reiniger G, Blasini R, Brügmann U, Rudolph W. Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768 [Abstract] [Full Text] [Related]
40. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin]. Ol'binskaia LI, Sizova ZhM, Ushakova AV. Ter Arkh; 1998 Jun; 70(5):69-72. PubMed ID: 9644750 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]